สืบค้นงานวิจัย
Biomedical applications of monoclonal antibodies (McAb) against entamoeba histolytzca
Thammapalerd N. - ไม่ระบุหน่วยงาน
ชื่อเรื่อง (EN): Biomedical applications of monoclonal antibodies (McAb) against entamoeba histolytzca
ผู้แต่ง / หัวหน้าโครงการ (EN): Thammapalerd N.
บทคัดย่อ (EN): Amebiasis, a disease caused by Entamoeba histolytica, with or without clinical symptoms, occurs throughout the world, especially in tropical and subtropical climates and in places with poor sanitary conditions due to fecal contamination of water and food or direct fecal-oral contact. E. histolytica is the third leading parasitic cause of death in the world after malaria and schistosomiasis and infects about 10% of the world’s population, 10% again of whom (approximately 48 million cases) develop invasive colitis or liver abscess with at least 40,000 deaths per year, while the other 90% are asymptomatic. 1 The high percentage of asymptomatic cases suggests that differences in invasiveness and/or pathogenicity occur among two different isolates of amebae, pathogenic and nonpathogenic strains, as first mentioned by Brumpt in 1925. 2 In vitro and in vivo experimental studies have demonstrated that E. histolytica adherence and cytolytic mechanisms are absolutely required for the pathogenesis of amebiasis. 35 Intestinal amebiasis occurs after ingestion of contaminating mature cysts. Excystation occurs in the lower ileum followed by intestinal colonization via adherence of ameba trophozoites to gut epithelial cells throughout the colon. Encystation takes place in the lower colon and the cysts leave the host via feces. Pathogenic amebae invade the intestinal wall, causing lesions and the symptoms of amebic colitis, and if they spread via the blood stream they may reach and invade other organs of the body, especially the liver, lung, and brain, causing extraintestinal amebiasis. Amebic brain infection causes changes in the CSF that mimic meningitis. Therefore, development of vaccines effective in preventing invasive amebiasis and even intestinal colonization by amebae would be the most cost-effective approach for prevention. 4 To develop a vaccine against amebiasis or other parasitic infections using recombinant DNA or synthetic peptide approaches, it is important to identify protective antigens, which may be facilitated by the use of monoclonal antibodies (McAb). E. histolytica-specific McAb have been produced in many laboratories 6 - 8 and have been used in a McAb-based ELISA for detection of amebic antigen in clinical specimens, 9 for typing of pathogenic amebae, 10 for prevention of parasite-mediated cytotoxicity of target cells, 7 for characterization of proteins involved in adherence to target cells, 11 for amebic antigen purification, 8 and hopefully in the future for the development of vaccine against invasive amebiasis. © 1991 by CRC Press, Inc.
บทคัดย่อ: ไม่พบข้อมูลจากหน่วยงานต้นทาง
ภาษา (EN): en
เอกสารแนบ (EN): https://www.scopus.com/inward/record.uri?eid=2-s2.0-85051543007&doi=10.1201%2f9781351070300&partnerID=40&md5=a41337e4eedda99b45c78e9f1d8a5698
เผยแพร่โดย (EN): มหาวิทยาลัยมหิดล
คำสำคัญ (EN): Parasite
เจ้าของลิขสิทธิ์ (EN): มหาวิทยาลัยมหิดล
หากไม่พบเอกสารฉบับเต็ม (Full Text) โปรดติดต่อหน่วยงานเจ้าของข้อมูล

การอ้างอิง

Thammapalerd N.. "Biomedical applications of monoclonal antibodies (McAb) against entamoeba histolytzca". ไม่ระบุหน่วยงาน. ม.ป.ป.

Thammapalerd N.. "Biomedical applications of monoclonal antibodies (McAb) against entamoeba histolytzca". ไม่ระบุหน่วยงาน. ม.ป.ป.. Print.



TARR Wordcloud:
Biomedical applications of monoclonal antibodies (McAb) against entamoeba histolytzca
Thammapalerd N.
มหาวิทยาลัยมหิดล
ไม่ระบุวันที่เผยแพร่
Bead array for Listeria monocytogenes detection using specific monoclonal antibodies HIV-1- specific IgA monoclonal antibodies from an HIV-1 vaccinee mediate galactosylceramide blocking and phagocytosis Development of monoclonal antibodies specific to ToxA and ToxB of Vibrio parahaemolyticus that cause acute hepatopancreatic necrosis disease (AHPND) Broad-spectrum monoclonal antibodies against chikungunya virus structural proteins: Promising candidates for antibody-based rapid diagnostic test development Potent neutralizing human monoclonal antibodies preferentially target mature dengue virus particles: Implication for novel strategy for dengue vaccine Applications of microalgal biotechnology for disease control in aquaculture Applications of in vitro Methods for the Multiplication of New Planting Material Nicotinic acid and derivatives as multifunctional pharmacophores for medical applications MAGNETITE (Fe3O4) EMBEDDED NR NANOCOMPOSITES FOR EMI SHIELDING APPLICATIONS Potential of RNAi applications to control viral diseases of farmed shrimp
คัดลอก URL
กระทู้ของฉัน
ผลการสืบค้นทั้งหมด โพสต์     เรียงลำดับจาก
พัฒนาระบบโดยศูนย์ความรู้เฉพาะด้านวิศวกรรมความรู้และวิศวกรรมภาษาDeveloped by Center of Excellence for Unified Knowledge and Language Engineering
สนับสนุนโดยสำนักงานพัฒนาการวิจัยการเกษตร (องค์การมหาชน)Supported by the Agricultural Research Development Agency (Public Organization)
แบบสำรวจความพึงพอใจQuestionair